Skip to content

Assessing the effectiveness of Ayurvedic Protocol, such as emesis, Blood letting, and Oral administration of Medicated Ghrita in patients of Psoriasis.

A clinical evaluation of an ayurvedic protocol (Vamana, Raktamokshana, Shamana Snehapana) in the management of EK Kushtha W.S.R. to Psoriasis: An open labelled Single-Arm clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098970
Enrollment
15
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Government Akhandanand Ayurveda college and Hospital, Bhadra, Ahemdabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to participate in clinical trial and ready for pathyapalana Patient having clinical signs and symptoms of Ekkushtha (Psoriasis) Patients with hemoglobin levels within the normal reference range (13.5 to 17.5g/dL for males and 12.0 to 15.5 g/dL for females) Vamana yogya Snehpana yogya Raktamokshana (Siravedhana) yogya.

Exclusion criteria

Exclusion criteria: Patient with Complications of psoriasis such as psoriatic arthritis, other autoimmune diseases etc. patients who are not willing to be included in the study. pregnant and Lactating women. Patients with K/C/O severe Cardiac pathology, Kidney disease like TB, AIDS, Other STDs. Patients taking medications like hormonal therapy, anti-depressants, Anticoagulants, or any other drugs which may affect outcome of the study. Patients with abnormal ECG findings will be excluded. Patients with alcohol addiction or drug abuse.

Design outcomes

Primary

MeasureTime frame
improvement in as symptoms of ekkushtha.Timepoint: Follow up will be done for 1 month after completion of treatment.

Secondary

MeasureTime frame
to study efficacy of treatmentTimepoint: Follow up will be done for 1 month after completion of treatment.

Countries

India

Contacts

Public ContactDr Krupali Raut

Government Akhandanand Ayurveda college and Hospital

rautkajal77@gmail.com9427149250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026